Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia

Tumor lysis syndrome (TLS) occurs when tumor cells release their contents into the bloodstream, typically in response to chemotherapy, leading to the characteristic findings of hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury. Twinkle artifacts on renal ultrasoun...

Descripción completa

Detalles Bibliográficos
Autor principal: Koratala, Abhilash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715431/
https://www.ncbi.nlm.nih.gov/pubmed/29225880
http://dx.doi.org/10.1002/ccr3.1268
_version_ 1783283766714695680
author Koratala, Abhilash
author_facet Koratala, Abhilash
author_sort Koratala, Abhilash
collection PubMed
description Tumor lysis syndrome (TLS) occurs when tumor cells release their contents into the bloodstream, typically in response to chemotherapy, leading to the characteristic findings of hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury. Twinkle artifacts on renal ultrasound may indicate calcium phosphate deposits in such patients.
format Online
Article
Text
id pubmed-5715431
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57154312017-12-08 Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia Koratala, Abhilash Clin Case Rep Clinical Images Tumor lysis syndrome (TLS) occurs when tumor cells release their contents into the bloodstream, typically in response to chemotherapy, leading to the characteristic findings of hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury. Twinkle artifacts on renal ultrasound may indicate calcium phosphate deposits in such patients. John Wiley and Sons Inc. 2017-11-13 /pmc/articles/PMC5715431/ /pubmed/29225880 http://dx.doi.org/10.1002/ccr3.1268 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Clinical Images
Koratala, Abhilash
Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
title Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
title_full Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
title_fullStr Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
title_full_unstemmed Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
title_short Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
title_sort tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715431/
https://www.ncbi.nlm.nih.gov/pubmed/29225880
http://dx.doi.org/10.1002/ccr3.1268
work_keys_str_mv AT koratalaabhilash tumorlysissyndromewithmassivehyperphosphatemiaandhyperuricemia

Ejemplares similares